Dr. Weeman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
2600 Sixth Street SW
Breast Care Center
Canton, OH 44710Phone+1 330-363-4363Fax+1 330-363-2282- Is this information wrong?
Education & Training
- Case Western Reserve University/University Hospitals Cleveland Medical CenterFellowship, Hematology and Medical Oncology, 1995 - 1996
- Saint Joseph HospitalResidency, Internal Medicine, 1989 - 1992
- Ohio State University College of MedicineClass of 1989
Certifications & Licensure
- OH State Medical License 1995 - 2019
Clinical Trials
- Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Start of enrollment: 2008 Aug 08
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia Start of enrollment: 2009 Jan 29
- Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer Start of enrollment: 2009 Jul 15
- Join now to see all
Publications & Presentations
PubMed
- 34 citationsProspective Statewide Study of Universal Screening for Hereditary Colorectal Cancer: The Ohio Colorectal Cancer Prevention Initiative.Rachel Pearlman, Wendy L. Frankel, Benjamin Swanson, Dan Jones, Weiqiang Zhao, Ahmet Yilmaz, Kristin Miller, Jason Bacher, Christopher Bigley, Lori Nelsen, Paul J. Goo...> ;JCO Precision Oncology. 2021 May 5
- 407 citationsPrevalence and Spectrum of Germline Cancer Susceptibility Gene Mutations Among Patients With Early-Onset Colorectal Cancer.Rachel Pearlman, Wendy L. Frankel, Benjamin Swanson, Weiqiang Zhao, Ahmet Yilmaz, Kristin Miller, Jason Bacher, Christopher Bigley, Lori Nelsen, Paul J. Goodfellow, Ri...> ;JAMA Oncology. 2017 Apr 1
- 96 citationsDNA glycosylases involved in base excision repair may be associated with cancer risk in BRCA1 and BRCA2 mutation carriersAna Osorio, Roger L. Milne, Karoline Kuchenbaecker, Tereza Vaclova, Guillermo Pita, Rosario Alonso, Paolo Peterlongo, Ignacio Blanco, Miguel de la Hoya, Mercedes Durán...> ;Plos Genetics. 2014 Apr 3
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: